News about Global Pharma

Gland Pharma Secures USFDA Approval for Latanoprostene Bunod Ophthalmic Solution

Gland Pharma has received USFDA approval for its generic version of Latanoprostene Bunod Ophthalmic Solution, 0.024 percent, securing first-to-file status with 180 days of generic drug exclusivity.

Global Pharma | 01/05/2025 | By Manvi |  565

Strides Pharma Secures USFDA Approval for Celecoxib Capsules

Strides Pharma has announced that its Singapore-based step-down subsidiary has received USFDA approval for Celecoxib Capsules (100 mg, 200 mg, and 400 mg), a generic equivalent of Celebrex, strengthening its presence in the anti-inflammatory segment.

Global Pharma | 01/05/2025 | By Manvi |  303

FDA-Approved Wegovy Now Easier to Access via Novo Nordisk's New Telehealth Initiative

In March 2025, Novo Nordisk launched NovoCare® Pharmacy to provide direct-to-patient, convenient home shipments of all dose strengths of Wegovy® at a reduced cost.

Global Pharma | 30/04/2025 | By Abha |  583

Zydus Secures Final Approval from USFDA for Niacin Extended-Release Tablets

Zydus Lifesciences has received final USFDA approval to manufacture Niacin Extended-Release Tablets in 500 mg, 750 mg, and 1,000 mg dosage, targeting cholesterol management and cardiovascular risk reduction.

Global Pharma | 30/04/2025 | By Abha |  592

Transneural Therapeutics Appoints Dr. Mark Demitrack as Chief Research and Development Officer

Dr. Demitrack is an accomplished, internationally recognised neuropsychiatrist with deep expertise in innovative clinical research and strategic business planning.

Global Pharma | 30/04/2025 | By Abha |  475

Navamedic Extends Imdur Distribution Agreement Until 2032

Imdur® (isosorbide mononitrate), is a prescription medication used to prevent angina pectoris due to heart disease.

Global Pharma | 30/04/2025 | By Abha |  629

PredxBio and Hamamatsu Partner to Advance Spatial Biology for Cancer Research

PredxBio, an AI-driven spatial biomarker discovery company, has entered into a strategic collaboration with Hamamatsu Photonics to combine advanced imaging and analytics technologies for accelerating cancer research and immuno-oncology discoveries.

Global Pharma | 29/04/2025 | By Manvi |  286

Nipro India Unveils Glass Cartridge Expansion at Pune Plant

The Nipro Pune plant is an experienced manufacturing site that has been producing premium-quality glass containers for leading Indian and global pharmaceutical companies for years.

Global Pharma | 29/04/2025 | By Abha |  702

Morepen to Expand Portfolio with Launch of Resmetirom for Fatty Liver Disease

Morepen Laboratories Ltd. has received approval from the Subject Expert Committee (SEC) of the CDSCO to initiate Bioequivalence studies for Resmetirom, a promising new therapy for non-alcoholic steatohepatitis (NASH), marking a key step in its expansion into the hepatology segment.

Global Pharma | 29/04/2025 | By Manvi |  511

Healthy.io Signs Agreement to Acquire Labrador Health

This strategic acquisition marks a step forward in Healthy.io's mission of transforming home-based diagnostics with lab-quality accuracy, powered by the smartphone.

Global Pharma | 29/04/2025 | By Manvi |  205